Huawei is taking a prevention-first route into the blood sugar monitoring race.
With the Huawei Watch GT 6 Pro, the company brings diabetes-risk screening to the wrist through its Diabetes Risk Study feature. Instead of waiting for blood sugar to become an obvious concern, the watch looks for health patterns worth reviewing.
As one of the first major smartwatch brands with a non-invasive diabetes risk assessment feature, Huawei gives wearables a more active role in prevention.
Daily health signals turn into a longer-range health check
Running in the background, the Diabetes Risk Study collects data while users wear the watch as usual. It reviews three to 14 days of wrist-based data tied to diabetes risk, so consistent wear gives the Watch GT 6 Pro a broader view than a single snapshot can provide.
Inputs include heart rate, heart rate variability, sleep, activity, and movement, which are used to assign a Low, Medium, or High category once sufficient data have been collected. The feature uses the watch’s optical health sensors, including PPG technology, to review changes in wrist-based health data over time.
No chart-reading or sensor expertise is required. The feature consolidates several everyday health signals into a single, easy-to-read category, making diabetes risk easier to spot without requiring people to interpret each metric individually.
What Low, Medium, and High risk results mean
Users do not need to panic over one result. Repeated Medium or High alerts are better treated as cues for medical follow-up, not as diagnoses. A No Result status can appear when more daytime or nighttime data is needed, meaning users should keep wearing the watch to complete the assessment cycle.
Small changes may help because the score can reflect sleep, stress, diet, alcohol, and activity. The alert may also give users a specific reason to ask about blood sugar testing at their next doctor’s visit.
The Diabetes Risk Study is best suited to adults monitoring long-term blood sugar risk, including those with a family history of Type 2 diabetes or concerns about Type 2 diabetes. According to Huawei, it is not suitable for Type 1 or gestational diabetes.
Prevention defines its place in the diabetes race
By bringing diabetes risk into everyday smartwatch tracking, the Watch GT 6 Pro adds a warning layer that casual health metrics usually do not provide. While the Apple Watch and Samsung Galaxy Watch are often discussed in terms of glucose readings and connected glucose monitors, Huawei’s current focus is on earlier risk awareness.
The Diabetes Risk Study is an awareness tool, not a diagnosis, so users should rely on blood tests, approved glucose monitors, and medical advice for diabetes management or treatment.
The feature is currently available on the Huawei Watch GT 6 Pro, with planned upgrades listed for the Watch 5 and Watch Ultimate 2. Availability spans markets including the UAE, Saudi Arabia, Bahrain, Qatar, Kuwait, Oman, Egypt, Jordan, Lebanon, Iraq, South Africa, Ghana, and Mauritius. The device is not currently available in the US, limiting its reach in one of the biggest smartwatch markets.
Huawei brings diabetes risk alerts closer to everyday life
Huawei’s Diabetes Risk Study could gain a larger role if it helps people act before diabetes reaches an urgent stage.
An alert cannot answer every question, but it can give someone a reason to schedule a checkup or take daily habits more seriously. Wider rollout would bring that kind of warning to people who may not be thinking about diabetes risk yet.
Expanded availability, additional validation, and clearer guidance will determine what comes next for Huawei. If diabetes-risk alerts reach other watches and prove useful over time, they could give users a reason to pay attention, ask better questions, and seek proper testing.
If blood sugar data is the next wearable feature on your radar, this guide shows which brands are making progress and which claims still need time.
